Revisions of 'Cerebral infarct - left MCA M1 & fetal PCA P2 occlusion'
-
Revision 9 - created over 1 year ago by Henry Knipe - view changesetDate: 2022-11-24 20:44:07 UTC Disclosures:
At the time the revision was created Henry Knipe had the following disclosures:
- Radiopaedia Events Pty Ltd, Speaker fees (past)
- Integral Diagnostics, Shareholder (ongoing)
- Micro-X Ltd, Shareholder (ongoing)
These were assessed during peer review and were determined to not be relevant to the changes that were made.
View Henry Knipe's current disclosures Reviewed by: Mohamed Saber -
Revision 8 - created over 1 year ago by Frank Gaillard - view changesetDate: 2022-11-24 11:24:31 UTC Disclosures:
At the time the revision was created Frank Gaillard had the following disclosures:
- Radiopaedia Australia Pty Ltd and Radiopaedia Events Pty Ltd, Director, Founder and CEO (Radiopaedia) (ongoing)
- Biogen Australia Pty Ltd, Investigator-Initiated Research Grant for CAD software in multiple sclerosis: finished Oct 2021 (past)
These were assessed during peer review and were determined to not be relevant to the changes that were made.
View Frank Gaillard's current disclosures Reviewed by: Henry Knipe -
Revision 7 - created over 1 year ago by Arkadi Tadevosyan - view changesetDate: 2022-11-24 10:01:15 UTC Disclosures:
At the time the revision was created Arkadi Tadevosyan had no financial relationships to ineligible companies to disclose.
View Arkadi Tadevosyan's current disclosures Reviewed by: Henry Knipe -
Revision 6 - created over 1 year ago by Arkadi Tadevosyan - view changesetDate: 2022-11-22 04:29:32 UTC Disclosures:
At the time the revision was created Arkadi Tadevosyan had no financial relationships to ineligible companies to disclose.
View Arkadi Tadevosyan's current disclosures Reviewed by: Frank Gaillard -
Revision 5 - created over 1 year ago by Arkadi Tadevosyan - view changesetDate: 2022-11-18 18:20:00 UTC Disclosures:
At the time the revision was created Arkadi Tadevosyan had no financial relationships to ineligible companies to disclose.
View Arkadi Tadevosyan's current disclosures Reviewed by: Frank Gaillard -
Revision 4 - created over 1 year ago by Arkadi Tadevosyan - view changesetDate: 2022-11-17 17:41:15 UTC Disclosures:
At the time the revision was created Arkadi Tadevosyan had no financial relationships to ineligible companies to disclose.
View Arkadi Tadevosyan's current disclosures Reviewed by: Frank Gaillard -
Revision 3 - created over 1 year ago by Arkadi Tadevosyan - view changesetDate: 2022-11-17 11:42:46 UTC Disclosures:
At the time the revision was created Arkadi Tadevosyan had no financial relationships to ineligible companies to disclose.
View Arkadi Tadevosyan's current disclosures Reviewed by: Frank Gaillard -
Revision 2 - created over 1 year ago by Arkadi Tadevosyan - view changesetDate: 2022-11-14 14:21:02 UTC Disclosures:
At the time the revision was created Arkadi Tadevosyan had no financial relationships to ineligible companies to disclose.
View Arkadi Tadevosyan's current disclosures Reviewed by: Frank Gaillard -
Revision 1 - created over 1 year ago by Arkadi Tadevosyan - view changesetDate: 2022-11-14 13:11:43 UTC Disclosures:
At the time the revision was created Arkadi Tadevosyan had no financial relationships to ineligible companies to disclose.
View Arkadi Tadevosyan's current disclosures Reviewed by: Henry Knipe
Unfortunately some older revisions may not be able to be viewed or restored.
Radiopaedia.org is a collaborative effort and anyone can contribute. Every revision counts. Learn more about contributing.
Each article also undergoes a sophisticated editorial process to ensure the high quality of Radiopaedia.org. Through open contributions by many different medical professionals, editorial oversight from our excellent editorial and expert review boards, and continual moderation, we can continue to provide the best, free radiology resource online.